G1m phenotype | AAA - | AAA + |
---|
3,3 | 108 (90%) | 12 (10%) |
3,17 | 83 (86%) | 14 (14%) |
17,17 | 19 (59%) | 13 (41%) |
- AAA -, anti-adalimumab antibodies negative; AAA +, anti-adalimumab antibodies positive.
- Patient numbers and corresponding percentages are shown. P = 0.0001 for the whole table.